[go: up one dir, main page]

WO2008157264A3 - Combined methods for the detection of chromosomal aneuploidy - Google Patents

Combined methods for the detection of chromosomal aneuploidy Download PDF

Info

Publication number
WO2008157264A3
WO2008157264A3 PCT/US2008/066791 US2008066791W WO2008157264A3 WO 2008157264 A3 WO2008157264 A3 WO 2008157264A3 US 2008066791 W US2008066791 W US 2008066791W WO 2008157264 A3 WO2008157264 A3 WO 2008157264A3
Authority
WO
WIPO (PCT)
Prior art keywords
detection
chromosomal aneuploidy
combined methods
fetal
diagnosis
Prior art date
Application number
PCT/US2008/066791
Other languages
French (fr)
Other versions
WO2008157264A2 (en
Inventor
Chari Georgiou Stylli
Original Assignee
Sequenom Inc
Chari Georgiou Stylli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequenom Inc, Chari Georgiou Stylli filed Critical Sequenom Inc
Publication of WO2008157264A2 publication Critical patent/WO2008157264A2/en
Publication of WO2008157264A3 publication Critical patent/WO2008157264A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to methods for the detection and/or diagnosis of fetal chromosomal abnormalities. In particular, the invention concerns the diagnosis of fetal chromosomal abnormalities by combining free, fetal nucleic acid-based tests with other one or more non-free, fetal nucleic acid-based chromosomal abnormality tests.
PCT/US2008/066791 2007-06-15 2008-06-12 Combined methods for the detection of chromosomal aneuploidy WO2008157264A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94433107P 2007-06-15 2007-06-15
US60/944,331 2007-06-15

Publications (2)

Publication Number Publication Date
WO2008157264A2 WO2008157264A2 (en) 2008-12-24
WO2008157264A3 true WO2008157264A3 (en) 2009-03-05

Family

ID=40156903

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/066791 WO2008157264A2 (en) 2007-06-15 2008-06-12 Combined methods for the detection of chromosomal aneuploidy

Country Status (1)

Country Link
WO (1) WO2008157264A2 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
EP2140031A4 (en) 2007-03-26 2011-04-20 Sequenom Inc DETECTION OF RESTRICTED ENDONUCLEASE-AMPLIFIED POLYMERIC SEQUENCE
US8206926B2 (en) 2008-03-26 2012-06-26 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
CA3116156C (en) 2008-08-04 2023-08-08 Natera, Inc. Methods for allele calling and ploidy calling
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
CN102216456A (en) 2008-09-16 2011-10-12 塞昆纳姆股份有限公司 Methods and compositions for methylation-based enrichment of fetal nucleic acid in maternal samples for non-invasive prenatal diagnosis
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
CN102597266A (en) 2009-09-30 2012-07-18 纳特拉公司 Methods for non-invasive prenatal ploidy calling
US9926593B2 (en) 2009-12-22 2018-03-27 Sequenom, Inc. Processes and kits for identifying aneuploidy
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
EP2854057B1 (en) 2010-05-18 2018-03-07 Natera, Inc. Methods for non-invasive pre-natal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
JP6328934B2 (en) 2010-12-22 2018-05-23 ナテラ， インコーポレイテッド Noninvasive prenatal testing
EP2673729B1 (en) 2011-02-09 2018-10-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
ES2930180T3 (en) 2012-03-02 2022-12-07 Sequenom Inc Methods for enriching for cancer nucleic acid from a biological sample
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
EP2872648B1 (en) 2012-07-13 2019-09-04 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
HK1216655A1 (en) 2013-03-13 2016-11-25 Sequenom, Inc. Primers for dna methylation analysis
US9499870B2 (en) 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
CN105814574B (en) 2013-10-04 2019-04-26 塞昆纳姆股份有限公司 Methods and procedures for non-invasive assessment of genetic variation
WO2015138774A1 (en) 2014-03-13 2015-09-17 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP6659575B2 (en) 2014-04-21 2020-03-04 ナテラ， インコーポレイテッド Mutation detection and chromosomal segment ploidy
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
EP3464626B1 (en) * 2016-05-27 2022-04-06 Sequenom, Inc. Methods for detecting genetic variations
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
EP3585889A1 (en) 2017-02-21 2020-01-01 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
CA3085933A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
JP7573443B2 (en) 2018-04-14 2024-10-25 ナテラ， インコーポレイテッド Methods for cancer detection and monitoring using personalized detection of circulating tumor dna - Patents.com
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
WO2020247263A1 (en) 2019-06-06 2020-12-10 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BIANCHI D.W.: "Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism", EUROPEAN JOURNAL OF OBSTETRICS & GYNAECOLOGY AND REPRODUCTIVE BIOLOGY, vol. 92, no. 1, September 2000 (2000-09-01), pages 103 - 108 *
HADDOW J.E. ET AL.: "Screening of material serum for fetal Down's syndrome in the first trimester", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 338, no. 14, 2 April 1998 (1998-04-02), pages 955 - 961 *
PRANAV P, ET AL.: "Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation", BJOG:AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, vol. 102, no. 12, 1995, pages 957 - 962 *
TRACY Y.H. ET AL.: "Fetal nucleic acids in maternal plasma", FETAL AND MATERNAL MEDICINE REVIEW, vol. 17, no. 2, 2006, pages 125 - 137 *
ZIMMERMANN LECTURER R. ET AL.: "Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities", BJOG: AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, vol. 103, no. 10, 1996, pages 1009 - 1014 *

Also Published As

Publication number Publication date
WO2008157264A2 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
WO2008157264A3 (en) Combined methods for the detection of chromosomal aneuploidy
WO2007100911A3 (en) Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2010075360A3 (en) Methods for detection of sepsis
WO2010132486A3 (en) Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
WO2009102446A3 (en) Fish assay for eml4 and alk fusion in lung cancer
WO2008097487A3 (en) Ultrasound imaging systems
WO2010009000A3 (en) Strip connectors for measurement devices
HK1214615A1 (en) Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2010062377A3 (en) Methods and compositions for the detection and treatment of preeclampsia
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2012012725A3 (en) Methods of detecting diseases or conditions using phagocytic cells
WO2008089397A3 (en) Adrb2 cancer markers
WO2009111643A3 (en) Microrna markers for recurrence of colorectal cancer
WO2012054639A3 (en) Nmr systems and methods for the rapid detection of analytes
WO2010065557A3 (en) Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis
WO2011065980A3 (en) Dyes for analysis of protein aggregation
WO2012054747A3 (en) Methods and compositions for treating tumors using myeloid derived suppressor cells
WO2014041185A3 (en) Colon cancer diagnostic method and means
GB0720113D0 (en) Diagnostic, prognostic and predictive testing for cancer
WO2010046648A3 (en) Diagnostic test for streptococcus equi
WO2010059242A3 (en) Neurodegenerative disease diagnostic compositions and methods of use
WO2013119950A3 (en) Methods and compositions relating to fusions of ros1 for diagnosing and treating cancer
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
WO2010009171A3 (en) Src activation for determining cancer prognosis and as a target for cancer therapy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08770904

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08770904

Country of ref document: EP

Kind code of ref document: A2